ArticleJournal of proteome research2025
metLinkR: Facilitating Metaanalysis of Human Metabolomics Data through Automated Linking of Metabolite Identifiers.
Article in Journal of proteome research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Computational metabolomics at scale: from open data to insight.Current opinion in biotechnology · 2026Review
- Purine-Metabolism Reprogramming Associated with Failed-Repair Proximal Tubule States in the AKI-to-CKD Transition.Metabolites · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Metabolites are referenced in spectral, structural and pathway databases with a diverse array of schemas, including various internal database identifiers and large tables of common name synonyms. Cross-linking metabolite identifiers is a required step for meta-analysis of metabolomic results across studies but made difficult due to the lack of a consensus identifier system. We have implemented metLinkR, an R package that leverages RefMet and RaMP-DB to automate and simplify cross-linking metabolite identifiers across studies and generating common names. MetLinkR accepts as input metabolite common names and identifiers from five different databases (HMDB, KEGG, ChEBI, LIPIDMAPS and PubChem) to exhaustively search for possible overlap in supplied metabolites from input data sets. In an example of 13 metabolomic data sets totaling 10,400 metabolites, metLinkR identified and provided common names for 1377 metabolites in common between at least 2 data sets in less than 18 min and produced standardized names for 74.4% of the input metabolites. In another example comprising five data sets with 3512 metabolites, metLinkR identified 715 metabolites in common between at least two data sets in under 12 min and produced standardized names for 82.3% of the input metabolites. Outputs of MetLInR include output tables and metrics allowing users to readily double check the mappings and to get an overview of chemical classes represented. Overall, MetLinkR provides a streamlined solution for a common task in metabolomic epidemiology and other fields that meta-analyze metabolomic data. The R package, vignette and source code are freely downloadable at https://github.com/ncats/metLinkR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.